ArticleOncoTargets and therapy2022

Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways.

Michał Janowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.